LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Medicine recalls, shortages and safety updates in the UK

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

expand all dayscollapse all days

6 Aug 2026Thursday 6 August 2026

open day ◀ ▶ 1 event
MHRA approval remibrutinib
As with any medicinal product, the MHRA will keep the safety and effectiveness of remibrutinib under close review.  
What this means, batches, details

Loading…

MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency

23 Jul 2026Thursday 23 July 2026

open day ◀ ▶ 1 event
Medicines recall Tuzulby 20 mg prolonged-release chewable tablets
Class 4 defect notification · 3 products · DMRC-40198117 · PL: 49718/0143 · Neuraxpharm UK Ltd. · methylphenidate hydrochloride
Batches: 77951 (08/2028), 79949 (02/2029), 78001 (08/2028), 79961 (02/2029), 78011 (08/2028), 79974 (02/2029)
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

21 Jul 2026Tuesday 21 July 2026

open day ◀ ▶ 2 events · 1 important
Drug Safety Update Domperidone
The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), du…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency
MHRA approval world's first lower-carbon beclometasone inhalers
The new inhalers use a next-generation propellant designed to reduce environmental impact while maintaining the same established treatment.
What this means, batches, details

Loading…

MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency

20 Jul 2026Monday 20 July 2026

open day ◀ ▶ 1 event
Medicines recall Xaggitin XL 18 mg Prolonged-release Tablets
Class 4 defect notification · 4 products · DMRC- 39567957 · PL: 01883/0359 · Macarthys Laboratories Ltd Trading as Martindale Pharma · methylphenidate hydrochloride
Batches: 183155 (30/10/2027), 185442 (31/12/2027), 174975 (31/05/2027), 175037 (31/05/2027), 178223 (31/07/2027), 183931 (30/11/2027), 185438 (30/11/2027), 185439 (30/11/2027), 185440 (30/11/2027), 187560 (28/02/2028), 175426 (30/06/2027), 175428 (30/06/2027), 176698 (30/06/2027), 176699 (30/06/2027), 176700 (30/06/2027), 182875 (30/09/2027), 183003 (31/10/2027), 178338 (31/07/2027), 178432 (31/07/2027), 178481 (31/07/2027), 180343 (30/09/2027), 187926 (28/02/2028), 187927 (28/02/2028), 187928 (28/02/2028), 187929 (28/02/2028), 187930 (28/02/2028)
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

15 Jul 2026Wednesday 15 July 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Botulinum toxin type A products
Cases of iatrogenic botulism have been reported following the therapeutic or cosmetic use of botulinum toxin containing products where the toxin’s effect extends beyond the area of treatment. Patients…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency
← newer days older days →

In total 282 events.